- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 496.65M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $4.35B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $4.28B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $44M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $44M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $487M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $468M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.27B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.32B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $6.59B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $6.52B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $3.44B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $3.22B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $12.94B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $12.61B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 496M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $24M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $2M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $6.06B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $6.22B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.06 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.06 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $337M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $87M |
| Net Income | Q1 2025 · Mar 31, 2024 | $32M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $690M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $515M |
| Revenue | Q1 2025 · Mar 31, 2024 | $1.21B |